Human medicines European public assessment report (EPAR): Taxespira (previously Docetaxel Hospira UK Limited ), docetaxel, Stomach Neoplasms,Prostatic Neoplasms,Breast Neoplasms,Head and Neck Neoplasms,Carcinoma, Non-Small-Cell Lung, Date of authorisation: 28/08/2015, Revision: 8, Status: Withdrawn

2019 ◽  
Author(s):  
Keyword(s):  
Breast Neoplasms ◽  
Head And Neck ◽  
Prostatic Neoplasms ◽  
Stomach Neoplasms ◽  
Head And Neck Neoplasms ◽  
Small Cell ◽  
Small Cell Lung ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document